Search research articles
Contact Us
Filters
Showing results (191-200 of 588) with videos related to
Page
of 59
Sort By:
International Journal of Clinical Oncology
|
August 6, 2013
Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Cancer Research and Treatment
|
February 4, 2021
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Changhee Park, Miso Kim, Yoonjin Kwak, et al.
Blood
|
June 21, 2011
Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury
Aparna Krishnamoorthy, Amrendra Kumar Ajay, Dana Hoffmann, et al.
Cancer Research and Treatment
|
July 19, 2014
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
The Korean Journal of Internal Medicine
|
March 29, 2016
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Journal of Medical Virology
|
November 5, 2015
High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma
Yuri Cho, Su Jong Yu, Eun Ju Cho, et al.
Cancer Research and Treatment
|
October 25, 2013
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Journal of Cancer Research and Clinical Oncology
|
December 22, 2022
Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines
Jeongjae Lee, Bhumsuk Keam, Ha-Ram Park, et al.
Thoracic Cancer
|
April 5, 2016
Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, et al.
Diabetes
|
April 29, 2006
NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes
Hyun Bae Kim, Minyoung Kong, Tae Min Kim, et al.
Page
of 59
Search research articles
Search
Showing results (191-200 of 588) with videos related to
Sort By:
Page
of 59
International Journal of Clinical Oncology
|
August 6, 2013
Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Cancer Research and Treatment
|
February 4, 2021
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Changhee Park, Miso Kim, Yoonjin Kwak, et al.
Blood
|
June 21, 2011
Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury
Aparna Krishnamoorthy, Amrendra Kumar Ajay, Dana Hoffmann, et al.
Cancer Research and Treatment
|
July 19, 2014
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
The Korean Journal of Internal Medicine
|
March 29, 2016
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Journal of Medical Virology
|
November 5, 2015
High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma
Yuri Cho, Su Jong Yu, Eun Ju Cho, et al.
Cancer Research and Treatment
|
October 25, 2013
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Journal of Cancer Research and Clinical Oncology
|
December 22, 2022
Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines
Jeongjae Lee, Bhumsuk Keam, Ha-Ram Park, et al.
Thoracic Cancer
|
April 5, 2016
Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, et al.
Diabetes
|
April 29, 2006
NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes
Hyun Bae Kim, Minyoung Kong, Tae Min Kim, et al.
Page
of 59